120 likes | 411 Views
Massachusetts Biotechnology Council Massachusetts Pharmaceutical & Medical Device Marketing Regulations Michael Joachim Senior Corporate Counsel Genzyme Corporation April 9, 2009. Disclaimer. I am speaking on my own behalf today, and not on behalf of Genzyme Corporation. Overview. Approach
E N D
Massachusetts Biotechnology CouncilMassachusetts Pharmaceutical & Medical Device Marketing RegulationsMichael JoachimSenior Corporate CounselGenzyme CorporationApril 9, 2009
Disclaimer • I am speaking on my own behalf today, and not on behalf of Genzyme Corporation.
Overview • Approach • Code • Training • Disclosure
Approach • Proper equipment is essential
Equipment (alternative) • For some audiences . . .
The Perspective from the Field • An Onslaught • Federal law • New PhRMA Code (and New AdvaMed Code) • Other State laws • Institution requirements • AAMC • Registration • Anger, Frustration, Disbelief
General Approach • Acknowledge but be practical • Positive spin • Give context • Consultation
Code/Written Guidance • New Documents • Marketing Code of Conduct • Written Guidance • A Group Project • Include affected business areas • Include management • Keep it Simple • Keep real world interactions in mind • Remember context and audience • No citations, quotes
Training • Written • Oral • In-person • WebEx • Train the trainer • FAQs • Repetition • Be accessible – no question too small
The Importance of Management • Tone at the top • Responsibility for compliance • Train the trainers
Disclosure • Internal understanding • Who • Finance • Regulatory • Business Areas • Legal/Compliance • Disclosing the disclosure
Questions, Comments • My contact information: • michael.joachim@genzyme.com